Cell Culture Market worth $58.42 billion by 2031 | MarketsandMarkets™
Why this matters
The projected rapid expansion of the cell culture market underscores a broader thematic shift with implications for US institutional commercial real estate. As the life sciences sector accelerates, buoyed by advances in biotechnology and pharmaceutical R&D, demand for specialized lab and manufacturing space is poised to intensify. This growth trajectory signals sustained capital flow into life sciences real estate, a subsector that has demonstrated resilience amid broader market volatility. Institutional investors and fund managers are likely to recalibrate portfolios to capture this secular growth, prioritizing assets that can accommodate the complex infrastructure and regulatory requirements of cell culture and biomanufacturing tenants. Moreover, the sector’s expansion may influence lending patterns, with capital providers increasingly comfortable underwriting specialized life sciences facilities given their long-term lease profiles and tenant credit quality. This dynamic could further differentiate life sciences from traditional office or retail sectors, which face structural headwinds. The cell culture market’s robust CAGR projection thus serves as a bellwether for the evolving intersection of innovation-driven demand and capital allocation in US commercial real estate, reinforcing life sciences as a strategic growth pillar within institutional portfolios.
Editorial analysis · AI-assisted
DELRAY BEACH, Fla., June 25, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Cell Culture Market is projected to grow from about USD 33.07 billion in 2026 to USD 58.42 billion by 2031, at a CAGR of 12.1%. Br…
External link. Real Estate Trail does not republish source content.